X0202 SCHEDULE 13G/A 0000929638-25-003514 0002071860 XXXXXXXX LIVE 2 Ordinary shares, par value $0.0135 per share 03/31/2026 0002022416 Silexion Therapeutics Corp G1281K122 12 Abba Hillel Road Ramat-Gan L3 5250606 Rule 13d-1(c) Lind Global Fund III LP b DE 212500 0 212500 0 212500 N 4.96 PN (1) The reporting person's ownership consists of (i) 106,250 warrants to purchase ordinary shares (the "Series A-1 Warrants") and (ii) 106,250 warrants to purchase ordinary shares (the "Series A-2 Warrants, together with the Series A-1 Warrants, the "Warrants"). Such Warrants may not be exercised if, following such exercise, the reporting person's beneficial ownership would exceed 9.9%. Lind Global Partners III LLC b DE 212500 0 212500 0 212500 N 4.96 PN (1) The reporting person's ownership consists of (i) 106,250 Series A-1 Warrants and (ii) 106,250 Series A-2 Warrants. Such Warrants may not be exercised if, following such exercise, the reporting person's beneficial ownership would exceed 9.9%. EASTON JEFF b X1 212500 0 212500 0 212500 N 4.96 IN (1) The reporting person's ownership consists of (i) 106,250 Series A-1 Warrants and (ii) 106,250 Series A-2 Warrants. Such Warrants may not be exercised if, following such exercise, the reporting person's beneficial ownership would exceed 9.9%. Silexion Therapeutics Corp 12 Abba Hillel Road, Ramat-Gan, Israel, 5250606 This statement is filed by the following entities and individuals (collectively, referred to as the "Reporting Persons"): Lind Global Fund III LP, a Delaware limited partnership; Lind Global Partners III LLC, a Delaware limited liability company; and Jeff Easton, an individual and a citizen of the United States of America. Lind Global Partners III LLC, the general partner of Lind Global Fund III LP, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund III LP. Jeff Easton, the managing member of Lind Global Partners III LLC, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund III LP. The address of the principal business office for each of the Reporting Persons is: 444 Madison Ave, Floor 41 New York, NY 10022 See Row 4 of cover page for each Reporting Person. Y See Row 9 of cover page for each Reporting Person. See Row 11 of cover page for each Reporting Person. See Row 5 of cover page for each Reporting Person. See Row 6 of cover page for each Reporting Person. See Row 7 of cover page for each Reporting Person. See Row 8 of cover page for each Reporting Person. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Lind Global Fund III LP By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton 05/15/2026 Lind Global Partners III LLC By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton 05/15/2026 EASTON JEFF /s/ Jeff Easton 05/15/2026